Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azvudine dose-finding in treatment-naive HIV-1
NCT04109183Phase 2Completed
- Sponsor
- Genuine Biotech
- Start
- Oct 2017
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of azvudine in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Genuine Biotech. Started Oct 2017; status: completed.
02
Drugs
azvudine
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT04109183.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04109183.